ID   ARBK2_HUMAN             Reviewed;         688 AA.
AC   P35626; Q9UGW9;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   07-NOV-2018, entry version 183.
DE   RecName: Full=Beta-adrenergic receptor kinase 2;
DE            Short=Beta-ARK-2;
DE            EC=2.7.11.15;
DE   AltName: Full=G-protein-coupled receptor kinase 3 {ECO:0000312|MIM:109636};
GN   Name=GRK3 {ECO:0000312|MIM:109636}; Synonyms=ADRBK2, BARK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8427589; DOI=10.1006/bbrc.1993.1072;
RA   Parruti G., Ambrosini G., Sallese M., de Blasi A.;
RT   "Molecular cloning, functional expression and mRNA analysis of human
RT   beta-adrenergic receptor kinase 2.";
RL   Biochem. Biophys. Res. Commun. 190:475-481(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [3]
RP   UBIQUITINATION.
RX   PubMed=20596523; DOI=10.1371/journal.pone.0011332;
RA   Del Rincon S.V., Rogers J., Widschwendter M., Sun D., Sieburg H.B.,
RA   Spruck C.;
RT   "Development and validation of a method for profiling post-
RT   translational modification activities using protein microarrays.";
RL   PLoS ONE 5:E11332-E11332(2010).
RN   [4]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-50; SER-60 AND LYS-104.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Specifically phosphorylates the agonist-occupied form of
CC       the beta-adrenergic and closely related receptors.
CC   -!- PTM: Ubiquitinated. {ECO:0000269|PubMed:20596523}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. GPRK subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; X69117; CAA48870.1; -; mRNA.
DR   EMBL; AL022329; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS13832.1; -.
DR   PIR; JC1469; JC1469.
DR   RefSeq; NP_005151.2; NM_005160.3.
DR   UniGene; Hs.657494; -.
DR   UniGene; Hs.733960; -.
DR   ProteinModelPortal; P35626; -.
DR   SMR; P35626; -.
DR   BioGrid; 106666; 10.
DR   IntAct; P35626; 4.
DR   STRING; 9606.ENSP00000317578; -.
DR   BindingDB; P35626; -.
DR   ChEMBL; CHEMBL1075166; -.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   GuidetoPHARMACOLOGY; 1467; -.
DR   GlyConnect; 1034; -.
DR   iPTMnet; P35626; -.
DR   PhosphoSitePlus; P35626; -.
DR   BioMuta; ADRBK2; -.
DR   DMDM; 116241253; -.
DR   EPD; P35626; -.
DR   MaxQB; P35626; -.
DR   PaxDb; P35626; -.
DR   PeptideAtlas; P35626; -.
DR   PRIDE; P35626; -.
DR   ProteomicsDB; 55118; -.
DR   DNASU; 157; -.
DR   Ensembl; ENST00000324198; ENSP00000317578; ENSG00000100077.
DR   GeneID; 157; -.
DR   KEGG; hsa:157; -.
DR   UCSC; uc003abx.5; human.
DR   CTD; 157; -.
DR   DisGeNET; 157; -.
DR   EuPathDB; HostDB:ENSG00000100077.14; -.
DR   GeneCards; GRK3; -.
DR   H-InvDB; HIX0041309; -.
DR   HGNC; HGNC:290; GRK3.
DR   HPA; HPA000804; -.
DR   MIM; 109636; gene.
DR   neXtProt; NX_P35626; -.
DR   OpenTargets; ENSG00000100077; -.
DR   PharmGKB; PA41; -.
DR   eggNOG; KOG0986; Eukaryota.
DR   eggNOG; ENOG410YRQZ; LUCA.
DR   GeneTree; ENSGT00860000133699; -.
DR   HOGENOM; HOG000006742; -.
DR   HOVERGEN; HBG050559; -.
DR   InParanoid; P35626; -.
DR   KO; K00910; -.
DR   OMA; DHVQTHL; -.
DR   OrthoDB; EOG091G0AEI; -.
DR   PhylomeDB; P35626; -.
DR   TreeFam; TF313940; -.
DR   BRENDA; 2.7.11.15; 2681.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   SignaLink; P35626; -.
DR   SIGNOR; P35626; -.
DR   ChiTaRS; GRK3; human.
DR   GeneWiki; Beta_adrenergic_receptor_kinase-2; -.
DR   GenomeRNAi; 157; -.
DR   PRO; PR:P35626; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100077; Expressed in 200 organ(s), highest expression level in Brodmann (1909) area 23.
DR   ExpressionAtlas; P35626; baseline and differential.
DR   Genevisible; P35626; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0047696; F:beta-adrenergic receptor kinase activity; TAS:Reactome.
DR   GO; GO:0004703; F:G protein-coupled receptor kinase activity; IEA:Ensembl.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0031623; P:receptor internalization; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR000239; GPCR_kinase.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR016137; RGS.
DR   InterPro; IPR036305; RGS_sf.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00615; RGS; 1.
DR   PRINTS; PR00717; GPCRKINASE.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00315; RGS; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF48097; SSF48097; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50132; RGS; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Kinase; Nucleotide-binding;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Ubl conjugation.
FT   CHAIN         1    688       Beta-adrenergic receptor kinase 2.
FT                                /FTId=PRO_0000085632.
FT   DOMAIN       54    175       RGS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00171}.
FT   DOMAIN      191    453       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      454    521       AGC-kinase C-terminal.
FT   DOMAIN      558    652       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   NP_BIND     197    205       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION        1    190       N-terminal.
FT   ACT_SITE    317    317       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     220    220       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   VARIANT      50     50       R -> S (in dbSNP:rs55700971).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040380.
FT   VARIANT      60     60       N -> S (in dbSNP:rs55740593).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040381.
FT   VARIANT     104    104       R -> K (in a lung bronchoalveolar
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040382.
FT   VARIANT     409    409       V -> M (in dbSNP:rs2272859).
FT                                /FTId=VAR_028005.
FT   CONFLICT    308    308       M -> V (in Ref. 1; CAA48870).
FT                                {ECO:0000305}.
SQ   SEQUENCE   688 AA;  79710 MW;  50844236A01C1423 CRC64;
     MADLEAVLAD VSYLMAMEKS KATPAARASK RIVLPEPSIR SVMQKYLAER NEITFDKIFN
     QKIGFLLFKD FCLNEINEAV PQVKFYEEIK EYEKLDNEED RLCRSRQIYD AYIMKELLSC
     SHPFSKQAVE HVQSHLSKKQ VTSTLFQPYI EEICESLRGD IFQKFMESDK FTRFCQWKNV
     ELNIHLTMNE FSVHRIIGRG GFGEVYGCRK ADTGKMYAMK CLDKKRIKMK QGETLALNER
     IMLSLVSTGD CPFIVCMTYA FHTPDKLCFI LDLMNGGDLH YHLSQHGVFS EKEMRFYATE
     IILGLEHMHN RFVVYRDLKP ANILLDEHGH ARISDLGLAC DFSKKKPHAS VGTHGYMAPE
     VLQKGTAYDS SADWFSLGCM LFKLLRGHSP FRQHKTKDKH EIDRMTLTVN VELPDTFSPE
     LKSLLEGLLQ RDVSKRLGCH GGGSQEVKEH SFFKGVDWQH VYLQKYPPPL IPPRGEVNAA
     DAFDIGSFDE EDTKGIKLLD CDQELYKNFP LVISERWQQE VTETVYEAVN ADTDKIEARK
     RAKNKQLGHE EDYALGKDCI MHGYMLKLGN PFLTQWQRRY FYLFPNRLEW RGEGESRQNL
     LTMEQILSVE ETQIKDKKCI LFRIKGGKQF VLQCESDPEF VQWKKELNET FKEAQRLLRR
     APKFLNKPRS GTVELPKPSL CHRNSNGL
//
